20/06/2024 Healthcare
Clavsat 1.2, an Amoxicillin Potassium Clavulanate Injection, combines the antibiotic properties of amoxicillin with the beta-lactamase inhibitor clavulanate. This formulation is effective against a broad spectrum of bacterial infections, including those resistant to amoxicillin alone. Administered intravenously, Clavsat 1.2 ensures rapid absorption and distribution in treating severe infections. It is a critical tool in combating bacterial resistance and providing reliable therapy in hospital settings where intravenous administration is necessary.Available in PCD Franchise for injectable range and third party manufacturing.
Systole Remedies is a trusted Potassium Clavulanate Tablet Manufacturer in India, delivering high-quality, effective formulations that meet strict pha...
BP USP Augniche 625mg Tablet is a combination medicines. It is prescribed to treat various types of bacterial infections. It fights against the infect...
Enhance your beauty safely and affordably with medically-supervised skin whitening injections at Dot Clinics, where certified skin specialists use Swi...
OneKrit is one of the trusted injectable PCD companies offering a wide range of high-quality, WHO-GMP-certified injectables for critical care and emer...
More Details